Cel-Sci
CVM
#10616
Rank
โ‚ฌ17.58 M
Marketcap
1,01ย โ‚ฌ
Share price
-4.92%
Change (1 day)
-87.66%
Change (1 year)

Cel-Sci (CVM) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : โ‚ฌ9.39 Million

According to Cel-Sci 's latest financial reports the company's total liabilities are โ‚ฌ9.39 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Cel-Sci - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-09-30โ‚ฌ10.39 M-18.05%
2024-09-30โ‚ฌ12.68 M-22.45%
2023-09-30โ‚ฌ16.35 M-12.85%
2022-09-30โ‚ฌ18.76 M12.33%
2021-09-30โ‚ฌ16.7 M-5.87%
2020-09-30โ‚ฌ17.74 M-13.99%
2019-09-30โ‚ฌ20.63 M-19.06%
2018-09-30โ‚ฌ25.49 M13.98%
2017-09-30โ‚ฌ22.36 M-1.94%
2016-09-30โ‚ฌ22.8 M-23.51%
2015-09-30โ‚ฌ29.82 M328.57%
2014-09-30โ‚ฌ6.95 M127.4%
2013-09-30โ‚ฌ3.05 M-56.64%
2012-09-30โ‚ฌ7.05 M0.33%
2011-09-30โ‚ฌ7.03 M-3.7%
2010-09-30โ‚ฌ7.3 M-71.49%
2009-09-30โ‚ฌ25.61 M833.22%
2008-09-30โ‚ฌ2.74 M-35.52%
2007-09-30โ‚ฌ4.25 M-49.07%
2006-09-30โ‚ฌ8.35 M917.54%
2005-09-30โ‚ฌ0.82 M-26.7%
2004-09-30โ‚ฌ1.12 M-22.89%
2003-09-30โ‚ฌ1.45 M-47.34%
2002-09-30โ‚ฌ2.76 M394.78%
2001-09-30โ‚ฌ0.55 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ103.84 B 1,104,971.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ72.27 B 769,004.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
โ‚ฌ0.19 B 1,942.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
โ‚ฌ14.72 M 56.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ27.59 B 293,532.18%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
BioCryst Pharmaceuticals
BCRX
โ‚ฌ0.88 B 9,305.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ0.69 B 7,260.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
โ‚ฌ3.19 M-65.99%๐Ÿ‡บ๐Ÿ‡ธ USA